Skip to Content
Translational Research Program (TRP)
Contact CIP
Show menu
Search this site
Last Updated: 02/06/19

Head & Neck SPOREs

SPOREs in head and neck cancer support translational research on cancers of the upper aero-digestive tract. In 2015, approximately 359,718 people in the United States were living with oral cavity and pharynx cancer and 89,081 with larynx cancer. In 2019, it is estimated that there will be 53,000 new cases of oral cavity and pharynx cancer and an estimated 10,860 deaths. For cancer of the larynx, approximately 12,410 new cases and 3,760 deaths are estimated. Known risk factors for head & neck cancer include smoking, alcohol use, and human papillomavirus (HPV) infection. The first SPOREs in head and neck cancer were established in 2002, and co-funding for this program is received by the National Institute of Dental and Craniofacial Research.